Zymeworks (ZYME) EBITDA Margin Growth (3y) (2024 - 2026)
Powered by 
Analysis
Zymeworks (ZYME) EBITDA Margin Growth (3y) (2024 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | -377.00 |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | -204.00 |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 7,045.00 |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | -1,934.00 |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 7,261.00 |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 9,003.00 |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | -2,649.00 |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 30,461.00 |
| 10 | Zymeworks | 2.15 Bn | 1.88 Bn | - | -14,612.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -14,612.00 |
| Mar 31, 2026 | -188,005.00 |
| Dec 31, 2025 | -185,382.00 |
| Sep 30, 2025 | 183,396.00 |
| Jun 30, 2025 | 120,815.00 |
| Mar 31, 2025 | 369,915.00 |
| Dec 31, 2024 | 43,902.00 |
| Sep 30, 2024 | 117,334.00 |